若干苄基异喹啉类化合物的HPLC保留因子与抑制钙调素活性的关系

苄基异喹啉类化合物具有较强的拮抗钙调素的活性,测定这类化合物ＨＰＬＣ参数ＬｏｇＫ＇作为疏水参数与抑制钙调素的活性进行相关分析,结果表明活性随化合物亲脂性的增大而升高,二者较符合抛物线关系。     

钙调素拮抗剂──双苄基异喹啉类化合物结构与活性关系的研究

 双苄基异喹啉类化合物拮抗钙调素(CaM),抑制CaM激活的环核苷酸磷酸二酯酶(PDE),研究表明:蝙蝠葛碱和小檗胺分子中12位羟墓被芳香基团酯化或醚化时,芳香基团的电子云分布状态变化能增加或降低分子的拮抗活性;取代基中的次甲基数增加可以增强分子的拮抗活性。分子非极性端引入含氮基团,化合物的拮抗活性较低。测试的化合物中,E_6D_(12)和D_(14)的拮抗CaM活性较强,IC_(50)分别为0.58μmol/L0.58μmol/L和0.53μmol/L。实验结果表明,分子的拮抗活性与分子非极性端的疏水性、电子云分布状态以及分子空间结构等多种结构性质相关。     

若干蝙蝠葛碱衍生物对人红细胞膜Ca^2＋—Mg^2＋——ATPase活力的影响

本文测定了数种蝙蝠葛碱衍生物对钙调素激活的人红细胞膜Ｃａ＾２＋－Ｍｇ＾２＋－ＡＴＰａｓｅ和的影响,结果表明,这些化合物对该酶都有不同程度的抑制作用,其机制表现为性抑制,过量的ＣａＭ能完全逆转这些化合物所引起的抑制。当Ｃａ＾２＋－Ｍｇ＾２＋－ＡＴＰａｓｅ被胰蛋白酶限制性酶解完全活化后,其活力不再受ＣａＭ激活,但仍被这些化合物所抑制。     

苄基异喹啉类化合物 D20抑制钙调素激活磷酸二酯酶的研究

苄基异喹啉化合物是一类钙调素拮抗剂.对新合成的双苄基异喹啉化合物 D₂₀对钙调素依赖的磷酸二酯酶的抑制作用进行了研究,IC₅₀=5μmol/L,表明其拮抗作用大于三氟啦嗪,是强的拮抗剂.荧光分析表明,钙调素与化合物 D₂₀的结合常数为2.64(μmol/L)^-1,一个化合物 D₂₀分子与两个钙调素分子结合,并显示了结合方向性及空间位阻影响.     

新的药根碱三唑的合成与抗菌以及乙酰胆碱酯酶抑制活性评价北大核心CSCD

通过有机合成手段合成了四个新的含三唑的药根碱衍生物,利用1H NMR,13C NMR和MS确认了目标化合物的结构,对合成的化合物进行了抗菌和抑制乙酰胆碱酯酶(ACh E)和丁酰胆碱酯酶(Bu Ch E)的活性测试。目标化合物显示具有较好的抗菌活性,抗菌结果显示所制备的化合物抑菌MIC范围从1到64μg/m L,对一些敏感菌的活性和阳性药物罗红霉素相当。对乙酰胆碱酯酶(ACh E)的抑制也表现出较好的活性,IC50值从0.46μM到0.86μM,但这些化合物对丁酰胆碱酯酶(Bu Ch E)表现出较弱的活性IC50>100μM。药根碱三唑具有较好的抑制乙酰胆碱酯酶的活性,且具有较好的选择性,同时具有较好的抗菌活性而且拓展了抗菌谱,可能成为一种新型的抗菌和治疗老年痴呆的先导化合物。     

光敏胞质雄性不育小麦育性转换期叶片中NAD激酶和NADP磷酸酶的变化

由光敏感胞质雄性不育小麦育性转换敏感期叶片中NAD激酶和NAD磷酸酶的活性变化表明：在长光照（LD）处理下,光敏胞质雄性不育小麦（牡山羊草）白皮224在光敏感期,叶片中的NAD激酶总活性和钙调素非依赖性NAD激酶活性高于短日照处理。钙调素依赖NAD激酶则相反,在短日照（SD）条件下,其活性明显地高于LD处理。不育系在长日条件下钙调素依赖性和非依赖性NAD激酶活性的比例也发生了变化,其钙调素依赖性活性逐渐被钙调素非依赖性活性所取代。而可育系核供体白皮224在不同光照条件下,这类酶活性无明显的差异。至于NAD磷酸酶的活性变化,无论是光敏小麦成核供体白皮224在LD和SD下均呈下降趋势。     

若干蝙蝠葛碱衍生物对人红细胞膜Ca~(2+)-Mg~(2+)-ATPase活力的影响

本文测定了数种蝙蝠葛碱衍生物对钙调素(CaM)激活的人红细胞膜Ca~(2+)-Mg~(2+)-ATPase活力的影响。结果表明,这些化合物对该酶都有不同程度的抑制作用,其机制表现为竞争性抑制,过量的CaM能完全逆转这些化合物所引起的抑制。当Ca~(2+)-Mg~(2+)-ATPase被胰蛋白酶(trypsin)限制性酶解完全活化后,其活力不再受CaM激活,但仍被这些化合物所抑制。     

外源钙调素与拟南芥悬浮培养细胞结合位点的观测及其胞外效应

以拟南芥悬浮培养细胞为实验体系,借助外源荧光及同位素标记钙调素,研究结果表明外源钙调素不能被主动内吞入细胞内,而是主要以完整分子形式结合在细胞外表面;外源纯化钙调素可促进正向型质膜囊泡中的鸟苷酸三磷酸水解酶活性升高,也可引起拟南芥悬浮细胞质游离钙离子浓度的特异升高,表明外源钙调素可能通过细胞表面位点跨膜信号转换为细胞内信号,从而调节生物学活性。     

玉米非特异性脂转移蛋白的cDNA克隆和表达及表达产物的钙调素结合活性分析

用RT-PCR法克隆了成熟的玉米非特异性脂转移蛋白的cDNA,将它连接到表达质粒上并转化至大肠杆菌中表达。以钙调素凝胶覆盖法和钙调素亲和层析下拉实验对表达产物进行分析,证明它具有结合钙调素的活性,并且这种结合不依赖于Ca^2＋,与前期研究中钙调素结合蛋白-10和拟南芥非特异性脂转移蛋白1的结合特性相同。采用基因删除和缺失突变的方法研究玉米非特异性脂转移蛋白与钙调素结合的结构域,结果表明钙调素结合于47-60位氨基酸,预测的蛋白质二级结构为碱性双亲α-螺旋结构。     

选择标记法对钙调神经磷酸酶和钙调素结合位点的研究

钙调素是一种多功能的钙调节蛋白。在细胞调节中,它往往需要与细胞里一些活性物质。蛋白质、酶等相结合而进行作用。钙调神经磷酸酶(Calcineurin)是新近发现的一种活性直接受Ca~(2 )、钙调素调节的磷蛋白磷酸酶。因此,钙调素如何和钙调神经磷酸酶结合,它们的结合位点等问题就成为这两个领域的研究者共同关心且迫切需要解决的课题。最近,我们用     

Daurisoline derivatives inhibit the ability of calmodulin to stimulate cyclic nucleotide phosphodiesterase activity

Daurisoline alkaloid derivatives were found to be potent calmodulin (CaM) antagonists. The ability of daurisoline derivatives to attenuate the stimulatory effect on calmodulin activated cyclic nucleotides phosphodiesterase (CaM-PDE) was studied. These compounds did not inhibit the basal activity of this enzyme. The hydrophobicity of these compounds was related to their inhibitory potency. It is suggested that such drugs bind directly to calmodulin in a Ca2(+)-dependent fashion, as indicated by their ability to change calmodulin fluorescence.     

Effects of sulfhydryl agents,trifluoperazine, phosphatase inhibitors and tryptic proteolysis on calcineurin isolated from bovine cerebral cortex

Summary Calcineurin was dicovered as an inhibitor of calmodulin stimulated cyclic AMP phosphodiesterase and its ability to act as a calmodulin binding protein largely explains its inhibitory action on calmodulin regulated enzymes. Recent studies establish calcineurin as the enzyme protein phosphatase whose activity is regulated by calmodulin and a variety of divalent metals. In this work, we have investigated the effects of several agents including sulfhydryl agents, trifluoperazine (a calmodulin antagonist), PP_i, NaF and orthovanadate and of tryptic proteolysis on the calcineurin inhibition of cyclic AMP phosphodiesterase (called inhibitory activity) and on protein phosphatase activity. Inhibitors for sulfhydryl groups (pHMB, NEM) inhibited phosphatase activity without any effect on the inhibitory activity. Dithioerythritol completely reversed the inhibition by pHMB. Limited proteolysis of calcineurin caused an activation of basal phosphatase activity with a complete loss of inhibitory activity. Phosphatase activity of the proteolyzed calcineurin was not stimulated by calmodulin. The presence of calmodulin along with calcineurin during tryptic digestion appeared to preserve the stimulation of phosphatase by Ca²⁺-calmodulin. [³H]-Trifluoperazine (TFP) was found to be incorporated irreversibly into calcineurin in the presence of ultraviolet light. This incorporation was evident into the A and B subunits of calcineurin. TFP-caused a decrease in the phosphatase activity and an increase in its inhibitory activity. [³H]-TFP incorporation into the A subunit was drastically decreased in the proteolyzed calcineurin. This was also true when the [³H]-TFP incorporated calcineurin was subjected to tryptic proteolysis. The incorporation into the B unit was essentially unaffected in the trypsinized calcineurin. Phosphatase activity was inhibited by orthovanadate, NaF, PP_i, and EDTA. Inhibitions by these compounds were more pronounced when the phosphatase was determined in the presence of Ca²⁺-cahnodulin than in their absence.     

Allosteric inhibition of rat neuronal nitric-oxide synthase caused by interference with the binding of calmodulin to the enzyme

A sigmoid-type dependence on the inhibitor concentration was observed in the cytochrome c reductase activity for peptide inhibitors (mastoparan and melittin), calmodulin antagonists (W-7 and tamoxifen) and monobutyltin in a reconstituted system comprised of recombinant rat neuronal nitric-oxide synthase (nNOS) and calmodulin (CaM). The increase in the concentration of CaM in the system induced a decrease in the inhibitory effect, indicating that the inhibitors might interfere with the interaction between nNOS and CaM. The changes in the fluorescence spectra of dansylated CaM caused by the addition of mastoparan, melittin and monobutyltin indicated complex formation between CaM and those compounds, which led to the decrease in the effective concentration of CaM available to nNOS. The sigmoid-type inhibition of mastoparan and melittin fit the theoretical equations quite well, assuming that two CaM molecules bind cooperatively to one nNOS homodimer. Monobutyltin, tamoxifen and W-7 were found to inhibit nNOS activity by binding to the CaM binding site of the nNOS homodimer, in addition to the binding of the inhibitors to calmodulin. These compounds inhibited the L-citrulline formation of nNOS from L-arginine, and the inhibitory effects were abrogated by raising the concentration of calmodulin. It became clear that the binding of calmodulin to nNOS can be interfered with in two ways: (1) via a decrease in the effective concentration of calmodulin caused by complex formation between the inhibitor and calmodulin, and (2) via the inhibition of the binding of calmodulin to nNOS caused by the occupation of the binding site by the inhibitor.     

Calmodulin and protein kinase C antagonists also inhibit the Ca2+-dependent protein protease, calpain I

The calmodulin and C-kinase antagonists melittin, calmidazolium, N-(6-aminohexyl)-5-chloro-1-napthalenesulfonamide (W7), and trifluoperazine (TFP) also inhibit the activity of the human erythrocyte Ca2+-dependent protease, calpain I. W-5, the nonchlorinated derivative of W-7, was ineffective as an inhibitor of calpain I just as it is for calmodulin and protein kinase C. Dose response studies provided the following IC50 values: melittin, 2.6 microM; calmidazolium, 6.2 microM; trifluoperazine, 130 microM; W-7, 251 microM. These IC50 values indicate that the compounds have affinities 10 to 600 fold less for calpain I than for calmodulin; however, the affinities of the inhibitory compounds are comparable for calpain I and protein kinase C. Kinetic analysis indicates that the compounds are competitive inhibitors of calpain I with respect to substrate.     

Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart

Divalent metals used to support phosphodiesterase (EC 3.1.4.-) activity have been found to influence the substrate and enzyme specificity of many phosphodiesterase inhibitors in studies of the hydrolysis of cyclic AMP and cyclic GMP by the calmodulin-dependent and cyclic AMP-specific phosphodiesterases from bovine heart. Many compounds displayed marked differences in substrate specificity and inhibitory potency in the presence of Mg2+, as compared with Mn2+, when studied with the unactivated form of calmodulin-dependent phosphodiesterase, while few compounds displayed differences in the presence of calmodulin. With a single divalent metal, marked differences in inhibitory potency and substrate specificity were also observed in the absence or presence of calmodulin suggesting that alterations in calmodulin and/or Ca2+ levels may greatly affect the response to phosphodiesterase inhibitors. Divalent metals did not alter the effects of inhibitors on the hydrolysis of cyclic AMP by the cyclic AMP-specific phosphodiesterase, however divalent metals would probably indirectly influence the relative cellular level of cyclic AMP hydrolyzed by this enzyme, and therefore the effects of inhibitors, through metal effects on the calmodulin-dependent phosphodiesterase. No correlation was found between the inhibitory activity of the compounds, many of which were cyclic nucleotide analogs, and their ability to activate cyclic AMP-dependent or cyclic GMP-dependent protein kinases or to affect cyclic AMP-dependent protein kinase activity by displacing bound cyclic AMP.     

Interaction of alpha adrenergic antagonists with calmodulin

Several alpha-adrenergic antagonists inhibited the activation of calmodulin-stimulated phosphodiesterase at concentrations that had little or no effect on basal phosphodiesterase activity. The most potent of these compounds were phenoxybenzamine and dibenamine (IC50 values of about 1 microM); the amino acid ergot alkaloids ergocryptine, ergocristine, ergotamine and their dihydrogenated derivatives were less potent calmodulin-inhibitors (IC50 values of 35-80 microM). The amino ergot alkaloids ergonovine and methysergide were essentially devoid of inhibitory activity. A variety of other alpha 1-antagonists (phentolamine, tolazoline and prazosin), an alpha 2-antagonist (yohimbine), alpha-agonists (norepinephrine, phenylephrine and clonidine), beta-adrenergic antagonists (propranolol and practolol) and the beta-adrenergic agonist methoxyphenamine displayed little or no anti-calmodulin activity (IC50 values greater than 300 microM). Similarly, the alkylating agents chlorambucil and mechlorethamine also failed to inhibit calmodulin activity. Phenoxybenzamine and dibenamine inhibited calmodulin activity irreversibly, whereas the inhibition caused by other alpha adrenergic blocking agents was reversible. Phenoxybenzamine inhibited calmodulin activity by binding directly to it. This binding was calcium-dependent and irreversible. The irreversible binding and inhibition of calmodulin activity by phenoxybenzamine (or dibenamine) may serve as a useful tool for studying the sites at which drugs bind to calmodulin and may also be useful for studying the distribution and turnover of calmodulin.     

Is calmodulin inhibition involved in shape transformations induced by amphiphiles in erythrocytes?

Potent antihaemolytic and shape transforming amphiphilic compounds were studied for their ability to inhibit calmodulin-activated phosphodiesterase activity. Some echinocytogenic and stomatocytogenic amphiphiles were potent calmodulin inhibitors. The most potent echinocytogenic and stomatocytogenic amphiphiles, however, had no or only weak inhibitory effect. Our results show that there is no causal relationship between the ability of amphiphiles to induce antihaemolysis or shape transformations in erythrocytes and their ability to inhibit calmodulin-activated phosphodiesterase activity, and it is suggested that calmodulin is not involved in shape transformations induced by amphiphiles.     

Mechanism for ganglioside-mediated modulation of a calmodulin-dependent enzyme. Modulation of calmodulin-dependent cyclic nucleotide phosphodiesterase activity through binding of gangliosides to calmodulin and the enzyme.

Gangliosides were recently shown to bind to calmodulin (Higashi, H., Omori, A., and Yamagata, T. (1992) J. Biol. Chem. 267, 9831-9838). This prompted us to investigate the effects of gangliosides on the calmodulin-dependent enzyme, cyclic nucleotide phosphodiesterase. Several species of gangliosides competitively inhibited calmodulin-stimulated phosphodiesterase activity, with GD1b, GT1b, and GD1a being noted to do so particularly (group 1). GM1, GQ1b, and GM2 (group 2) were less inhibitory, and GM3, GM3(NeuGc), GalCer, sulfatide, GgOse4Cer, and oligosaccharide portions of inhibitory gangliosides showed no inhibition in accordance with the binding specificity of calmodulin to gangliosides. Trypsin-activated phosphodiesterase was inhibited by gangliosides with similar specificity, indicating interactions of gangliosides with the enzyme. Inhibition, however, was less than that of calmodulin-dependent activity by these compounds and, in both cases, was eliminated by excess calmodulin. In the absence of calmodulin, group 1 gangliosides at lower concentrations activated the intact enzyme but inhibited it over a certain range of increase in concentration. Ganglioside-dependent modulation of calmodulin-dependent phosphodiesterase activity is thus shown to be due to interactions of gangliosides with both calmodulin and the enzyme, and consequently, ganglioside-calmodulin binding is likely the mechanism for regulation of the enzyme.     

Inhibitory effect of organotin compounds on rat neuronal nitric oxide synthase through interaction with calmodulin

Organotin compounds, triphenyltin (TPT), tributyltin, dibutyltin, and monobutyltin (MBT), showed potent inhibitory effects on both L-arginine oxidation to nitric oxide and L-citrulline, and cytochrome c reduction catalyzed by recombinant rat neuronal nitric oxide synthase (nNOS). The two inhibitory effects were almost parallel. MBT and TPT showed the highest inhibitory effects, followed by tributyltin and dibutyltin; TPT and MBT showed inhibition constant (IC(50)) values of around 10microM. Cytochrome c reduction activity was markedly decreased by removal of calmodulin (CaM) from the complete mixture, and the decrease was similar to the extent of inhibition by TPT and MBT. The inhibitory effect of MBT on the cytochrome c reducing activity was rapidly attenuated upon dilution of the inhibitor, and addition of a high concentration of CaM reactivated the cytochrome c reduction activity inhibited by MBT. However, other cofactors such as FAD, FMN or tetrahydrobiopterin had no such ability. The inhibitory effect of organotin compounds (100microM) on L-arginine oxidation of nNOS almost vanished when the amount of CaM was sufficiently increased (150-300microM). It was confirmed by CaM-agarose column chromatography that the dissociation of nNOS-CaM complex was induced by organotin compounds. These results indicate that organotin compounds disturb the interaction between CaM and nNOS, thereby inhibiting electron transfer from the reductase domain to cytochrome c and the oxygenase domain.     

Syntheses and cytotoxicity evaluation of bis(indolyl)thiazole, bis(indolyl)pyrazinone and bis(indolyl)pyrazine: analogues of cytotoxic marine bis(indole) alkaloid

2,4-Bis(3'-indolyl)thiazoles, 3,5-bis(3'-indolyl)-2(1H)pyrazinone and 3,6-bis(3'-indolyl)pyrazine were synthesized and evaluated for cytotoxic activity against diverse human cancer cell lines by the National Cancer Institute. These compounds demonstrated significant inhibitory effects in the growth of a range of cancer cell lines. 2,4-Bis(3'-indolyl)thiazole displayed selective cytotoxicity against certain leukemia cell lines with GI50 values in the low micromolar range while the substituted derivatives showed a broad spectrum of cytotoxic activity. 3,5-Bis(3'-indolyl)-2(1H)pyrazinone and 3,6-bis[3'-(N-methyl-indolyl)]pyrazine possessed strong inhibitory activity against a wide range of human tumor cell lines. The mechanism of action remained unknown. The results suggested that 2,4-bis(3'-indolyl)thiazoles, 3,5-bis(3'-indolyl)-2(1H)pyrazinone and 3,6-bis[3'-(N-methyl-indolyl)] pyrazine offer potential as lead compounds for the discovery of anticancer agents.